Prevalence of chlamydia and gonorreheae among transgender women and travestis in five Brazilian capitals, 2019–2021 (Q30044)

From lgbtDB
Jump to navigation Jump to search
No description defined
  • Prevalence of chlamydia and gonorreheae among transgender women and travestis in five Brazilian capitals, 2019-2021.
Language Label Description Also known as
English
Prevalence of chlamydia and gonorreheae among transgender women and travestis in five Brazilian capitals, 2019–2021
No description defined
  • Prevalence of chlamydia and gonorreheae among transgender women and travestis in five Brazilian capitals, 2019-2021.

Statements

Prevalence of chlamydia and gonorreheae among transgender women and travestis in five Brazilian capitals, 2019-2021. (English)
1 reference
To estimate the prevalence and factors associated with the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in transgender women and travestis in five Brazilian capitals. (English)
1 reference
Data were obtained from a cross-sectional study conducted between 2019 and 2021, with participants recruited through Respondent Driven Sampling in São Paulo, Campo Grande, Manaus, Porto Alegre and Salvador. (English)
1 reference
Detection of CT and NG was analyzed at three collection sites (anorectal, oropharyngeal and urethral). (English)
1 reference
Mixed logistic regression models were employed to identify associated factors. (English)
1 reference
A total of 1,297 recruited participants provided biological material to detect these infections. (English)
1 reference
The prevalences of CT, NG and coinfection were 11.5%, 13.3% and 3.6%, respectively. (English)
1 reference
Independent associations with CT infections included past (OR=1.73; 95%CI 1.02-2.95), current (OR=2.13; 95%CI 1.23-3.69), and part-time sex work (OR=2.75; 95%CI 1.60-4.75), as well as lifetime injectable drug use (OR=3.54; 95%CI 1.49-8.40). (English)
1 reference
For NG, associations were observed with lifetime injectable drug use (OR=1.91; 95%CI 1.28-2.84) and sexual orientation, including heterosexual (OR=3.44; 95%CI 1.35-8.82), homosexual (OR=5.49; 95%CI 1.89-15.97), and bisexual (OR=3.21; 95%CI 1.06-9.68). (English)
1 reference
Coinfection was associated with use of illicit drugs in the last 12 months (OR=2.34, 95%CI 1.10-5.00), and younger age was associated with all investigated outcomes. (English)
1 reference
Estimated prevalences of CT, NG and co-infection were higher among transgender women and travestis compared to the general population, particularly among younger, individuals engaged in sex work and illicit drug use. (English)
1 reference
Estimar as prevalências e os fatores associados à detecção de <i>Chlamydia trachomatis</i> (CT) e <i>Neisseria gonorrhoeae</i> (NG) em mulheres trans e travestis em cinco capitais brasileiras. (Portuguese)
1 reference
Os dados vieram de um estudo transversal, realizado entre 2019 e 2021, com pessoas recrutadas por RDS (<i>respondent driven sampling</i>) em São Paulo, Campo Grande, Manaus, Porto Alegre e Salvador. (Portuguese)
1 reference
Analisou-se a detecção de CT e NG, em três sítios de coleta (anorretal, orofaríngeo e uretral). (Portuguese)
1 reference
Para identificação dos fatores associados empregaram-se modelos logísticos com efeitos mistos. (Portuguese)
1 reference
Forneceram material biológico para detecção dessas infecções 1.297 participantes recrutadas. (Portuguese)
1 reference
As prevalências de CT, NG e coinfecção foram, respectivamente, 11,5, 13,3 e 3,6%. (Portuguese)
1 reference
Foram independentemente associados à detecção para CT: trabalho sexual no passado (<i>odds ratio</i> — OR=1,73; intervalos de confiança para 95% — IC95% 1,02–2,95), no momento atual (OR=2,13; IC95% 1,23–3,69) e como atividade parcial (OR=2,75; IC95% 1,60–4,75) e uso de drogas injetáveis na vida (OR=3,54; IC95% 1,49–8,40). (Portuguese)
1 reference
Para NG: uso de drogas injetáveis na vida (OR=1,91; IC95% 1,28–2,84) e orientação sexual – heterossexuais (OR=3,44; IC95% 1,35–8,82), homossexuais (OR=5,49; IC95% 1,89–15,97) e bissexuais (OR=3,21; IC95% 1,06–9,68). (Portuguese)
1 reference
Para coinfecção: uso de drogas nos últimos 12 meses (OR=2,34; IC95% 1,10–5,00). (Portuguese)
1 reference
Ser mais jovem foi associada a todos os desfechos investigados. (Portuguese)
1 reference
As prevalências estimadas de CT, NG e de coinfecção foram desproporcionalmente mais elevadas entre as mulheres trans e travestis se comparadas à população geral, especialmente entre as mais jovens, que exerciam trabalho sexual e faziam uso de drogas. (Portuguese)
1 reference
2024
1 reference
2024
1 reference
27Suppl 1
1 reference
Suppl 1
1 reference
e240006.supl.1
1 reference
e240006.supl.1
1 reference
S1415-790X2024000200404
1 reference
<b>Conflict of interest:</b> nothing to declare. (English)
1 reference